States Targeted for passage of the KCPA include;
Oregon, Missouri, Ohio, Idaho, Illinois, Tennessee, Colorado, Michigan, Alabama, Kansas, Wisconsin, Florida, Louisiana, West Virginia, South Carolina, Mississippi, Virginia, Pennsylvania, Oklahoma, North Carolina, New York.
States where AKA is handling contact with states officials directly;
Arkansas, Rhode Island, Texas.
Some states, like Texas and Arkansas, do not have legislative sessions scheduled in 2020, but there are official “interim meetings” where legislators meet to review proposed legislation and policies. In those states, the AKA will directly educate and prepare legislators for the introduction and passage of the KCPA in 2021.
What does the KCPA do?
The Kratom Consumer Protection Act (KCPA) adds ‘common-sense regulation’ to kratom products. As a consumer, this is great news! After all, it was frustration with the lack of consistency, standards, and information that provided the basis for Victor and me to embark on the mission to become the most trusted source of kratom and effective botanical products.
I am proud to say ETHA Natural Medicine already implemented these proposed rules due to ETHA Internal policies and standards. Simply put, we manufacture and sell the world’s best 100% natural Kratom products!
KCPA Draft Legislation:
(1) Product Registration: All vendors have to register with the designated state agency and provide independent lab certifications their product complies with the requirements of the KCPA in that state;
(2) Age Restriction: No sale of any kratom product to anyone under the age of 18 – (some states require a ban on sales to anyone under the age of 21;
(3) Labeling Requirements: Clear labeling on the contents of any kratom product;
(4) No Adulteration: A ban on adding any dangerous non-kratom substance, or a substance that affects the quality or strength of a kratom product to the degree it renders the product injurious to a consumer, including adding any controlled substance(s);
(5) No Synthetic Alkaloids: A ban on adding any synthetic kratom alkaloids (mitragynine or 7- hydroxymitragynine) or compounds of the plant;
(6) Limit on 7-OH: A ban on any kratom product that contains a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than 2% of the overall alkaloid composition of the product; and
(7) Appropriate warning labels: Include warnings that consumers should consult their doctors for any possible drug interactions with current medications prescribed to them; and warnings that pregnant women should not consume kratom because there is no safety data that has been published.
Looking forward to 2020; filled with excitement, hard work, and growth!